La qualité et la quantité de sommeil sont essentielles pour maintenir une bonne santé, et cela est d'autant plus vrai avec l'âge. Après 60 ans, les besoins en sommeil peuvent évoluer ...
En cliquant sur «Consulter», vous acceptez le dépôt de cookies par des services de contenus vidéo et audio Consulter Samedi 14 septembre 2024, un peu avant 17 h, sur la route départementale 4 à ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Roche raised hopes this year that it had a future blockbuster drug on its hands after early trial results ...
One person was killed in a fiery, single-car crash on the 60 Freeway in East Los Angeles early Saturday morning. The crash happened at around 5:30 a.m. in eastbound lanes of the road near S.
When Roche's Genentech gained approval for Ocrevus in 2017, the first-in-class infused drug quickly became the best-selling treatment in a crowded multiple sclerosis (MS) market. Three years later ...
Swiss pharma giant Roche won approval from the Food and Drug Administration on Friday for an injectable version of its blockbuster multiple sclerosis therapy Ocrevus, cutting down the time needed ...
The father of one was 31 when he was last seen alive in Kilkenny Dean Roche's car was found crashed into a tree Gardaí are to launch a review of the mysterious case of a man who was aged 31 when ...
La Roche-Posay Anthelios Invisible Fluid SPF 50 is a lightweight, non-greasy option that provides high protection while being gentle enough for sensitive skin. It offers broad-spectrum UVA and UVB ...
Roche shares fall 3.5% Early study trial showed high rate of temporary side effects JP Morgan analysts say heart rate increase is as a concern Roche plans slower ramp-up of pill dose in next trial ...
Shares of Roche (OTCQX:RHHBY) slid 5% Wednesday while shares of rivals Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) gained ground after Reuters reported that positive data released by Roche (OTCQX ...
ASX chairman Damian Roche will retire next month after four years as head of the board of the sharemarket operator, a period marked by the failed roll-out of critical settlement and clearing ...